Home / Cell Biology / Cell Metabolism / DNA, RNA and Protein Synthesis / Targapremir 210

Targapremir 210

Cat. No. 6586 Submit a Review Datasheet / COA / SDS

Discontinued Product

6586 has been discontinued.

View all DNA, RNA and Protein Synthesis products.
Description: Inhibits formation of miR-210
Chemical Name: N-(3-Azidopropyl)-4-[3-[6-(4-methyl-1-piperazinyl)[2,6'-bi-1H-benzimidazol]-2'-yl]phenoxy]butanamide
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (2)
Biological Activity Technical Data Datasheets References

Biological Activity for Targapremir 210

Targapremir 210 inhibits formation of mature miR-210 (IC50 = 200 nM) by binding to Dicer binding site of the miR-210 hairpin precursor (Kd = 200 nM) and inhibits Dicer processing of the miRNA. Decreases levels of miR-210 and HIF-1α mRNA, and induces apoptosis in MDA-MB-231 cells cultured under hypoxic conditions. Reduces tumor expression of HIF-1α mRNA and miR-210, and tumor growth in a triple negative breast cancer mouse model.

Technical Data for Targapremir 210

M. Wt 592.71
Formula C32H36N10O2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 1049722-30-6
PubChem ID 44221088
InChI Key PAYVJEWMAWLKAP-UHFFFAOYSA-N
Smiles CN1CCN(C2=CC=C3N=C(C4=CC=C5N=C(C6=CC(OCCCC(NCCCN=[N+]=[N-])=O)=CC=C6)NC5=C4)NC3=C2)CC1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Targapremir 210

Certificate of Analysis / Product Datasheet
Safety Datasheet

References for Targapremir 210

References are publications that support the biological activity of the product.

Costales et al (2017) Small molecule inhibition of microRNA-210 reprograms an oncogenic hypoxic circuit. J.Am.Chem.Soc. 139 3446 PMID: 28240549

Childs-Disney et al (2012) Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive. ACS.Chem.Biol 7 856 PMID: 22332923

View Related Products by Target

Keywords: Targapremir 210, Targapremir 210 supplier, micro, RNA, miRNA, inhibitors, inhibits, miR-210, triple, negative, breast, cancer, hypoxia, HIF1a, alpha, alfa, α, DNA,, and, Protein, Synthesis, 6586, Tocris Bioscience

Citations for Targapremir 210

Citations are publications that use Tocris products.

Currently there are no citations for Targapremir 210.

Reviews for Targapremir 210

There are currently no reviews for this product. Be the first to review Targapremir 210 and earn rewards!

Have you used Targapremir 210?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Cell Cycle and DNA Damage Research Product Guide

Cell Cycle and DNA Damage Research Product Guide

This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:

  • Cell Cycle and Mitosis
  • DNA Damage Repair
  • Targeted Protein Degradation
  • Ubiquitin Proteasome Pathway
  • Chemotherapy Targets
Huntington's Disease Research Product Guide

Huntington's Disease Research Product Guide

This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:

  • Somatic Instability
  • Proteolysis and Inclusion Bodies
  • Transcriptional Dysregulation
  • Mitochondrial Dysfunction
  • Nuclear-Cytoplasmic Transport Interference
  • Excitotoxicity
  • Stem Cells